Inventor
FENG JUN
US144 patents
⚠️ This page may combine multiple inventors who share the name “FENG JUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARAXES PHARMA LLC
31 patentsUS9926267B2Mar 27, 2018
Covalent inhibitors of K-Ras G12C
ARAXES PHARMA LLC38 citations98
US9840516B2Dec 12, 2017
Substituted quinazolines as inhibitors of KRAS G12C
ARAXES PHARMA LLC73 citations98
US9227978B2Jan 5, 2016
Covalent inhibitors of Kras G12C
ARAXES PHARMA LLC47 citations98
US10745385B2Aug 18, 2020
Covalent inhibitors of KRAS
ARAXES PHARMA LLC17 citations94
US10736897B2Aug 11, 2020
Compounds and methods of use thereof for treatment of cancer
ARAXES PHARMA LLC28 citations94
US10428064B2Oct 1, 2019
Fused-tricyclic inhibitors of KRAS and methods of use thereof
ARAXES PHARMA LLC27 citations94
US10414757B2Sep 17, 2019
2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof
ARAXES PHARMA LLC33 citations94
US10377743B2Aug 13, 2019
Inhibitors of RAS and methods of use thereof
ARAXES PHARMA LLC29 citations94
US10370386B2Aug 6, 2019
Substituted quinolines as inhibitors of KRAS G12C
ARAXES PHARMA LLC33 citations94
US10351550B2Jul 16, 2019
Substituted quinazoline compounds and methods of use thereof
ARAXES PHARMA LLC27 citations94
US10280172B2May 7, 2019
Inhibitors of KRAS G12C mutant proteins
ARAXES PHARMA LLC34 citations94
US10273207B2Apr 30, 2019
Covalent inhibitors of kras G12C
ARAXES PHARMA LLC24 citations94
US10246424B2Apr 2, 2019
Substituted quinazoline compounds and methods of use thereof
ARAXES PHARMA LLC36 citations94
US10144724B2Dec 4, 2018
Substituted quinazoline compounds and methods of use thereof
ARAXES PHARMA LLC44 citations94
US9862701B2Jan 9, 2018
Inhibitors of KRAS G12C mutant proteins
ARAXES PHARMA LLC45 citations94
US9745319B2Aug 29, 2017
Irreversible covalent inhibitors of the GTPase K-Ras G12C
ARAXES PHARMA LLC43 citations94
US10975071B2Apr 13, 2021
Inhibitors of KRAS G12C mutant proteins
ARAXES PHARMA LLC9 citations86
US10927125B2Feb 23, 2021
Substituted cinnolines as inhibitors of KRAS G12C
ARAXES PHARMA LLC11 citations86
US10919850B2Feb 16, 2021
Covalent inhibitors of KRas G12C
ARAXES PHARMA LLC9 citations86
US10882847B2Jan 5, 2021
Inhibitors of KRAS G12C mutant proteins
ARAXES PHARMA LLC11 citations86
US10875842B2Dec 29, 2020
Inhibitors of KRAS G12C mutant proteins
ARAXES PHARMA LLC11 citations86
US10858343B2Dec 8, 2020
Inhibitors of KRAS G12C mutant proteins
ARAXES PHARMA LLC11 citations86
US10829458B2Nov 10, 2020
Substituted quinazoline compounds and methods of use thereof
ARAXES PHARMA LLC13 citations86
US10730867B2Aug 4, 2020
Inhibitors of KRAS G12C mutant proteins
ARAXES PHARMA LLC15 citations86
US10723738B2Jul 28, 2020
Inhibitors of KRAS G12C mutant proteins
ARAXES PHARMA LLC15 citations86
US10689356B2Jun 23, 2020
Inhibitors of KRAS G12C mutant proteins
ARAXES PHARMA LLC16 citations86
US10647703B2May 12, 2020
Inhibitors of KRAS G12C mutant proteins
ARAXES PHARMA LLC18 citations86
US11059819B2Jul 13, 2021
Fused hetero-hetero bicyclic compounds and methods of use thereof
ARAXES PHARMA LLC8 citations84
US11021470B2Jun 1, 2021
2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof
ARAXES PHARMA LLC8 citations84
US10822312B2Nov 3, 2020
Substituted quinazoline compounds and methods of use
ARAXES PHARMA LLC10 citations84
US10011600B2Jul 3, 2018
Methods and compositions for inhibition of Ras
ARAXES PHARMA LLC12 citations84
HECHT THOMAS R
4 patentsUSD657369SApr 10, 2012
Display screen of a beverage dispenser with a graphical user interface
HECHT THOMAS R69 citations97
US9622615B2Apr 18, 2017
Touch screen interface for a beverage dispensing machine
HECHT THOMAS R27 citations94
USD657371SApr 10, 2012
Display screen of a beverage dispenser with a graphical user interface
HECHT THOMAS R46 citations93
USD657370SApr 10, 2012
Display screen of a beverage dispenser with a graphical user interface
HECHT THOMAS R36 citations92
TAKEDA PHARMACEUTICAL
4 patentsUS7781584B2Aug 24, 2010
Dipeptidyl peptidase inhibitors
TAKEDA PHARMACEUTICAL17 citations92
US7550590B2Jun 23, 2009
Dipeptidyl peptidase inhibitors
TAKEDA PHARMACEUTICAL20 citations92
US7470700B2Dec 30, 2008
Dipeptidyl peptidase inhibitors
TAKEDA PHARMACEUTICAL23 citations92
US7795428B2Sep 14, 2010
Dipeptidyl peptidase inhibitors
TAKEDA PHARMACEUTICAL12 citations89
KURA ONCOLOGY INC
3 patentsUS10588907B2Mar 17, 2020
Methods and compositions for inhibiting the interaction of menin with MLL proteins
KURA ONCOLOGY INC6 citations84
US10174041B2Jan 8, 2019
Methods and compositions for inhibiting the interaction of menin with MLL proteins
KURA ONCOLOGY INC11 citations84
US10077271B2Sep 18, 2018
Methods and compositions for inhibiting the interaction of menin with MLL proteins
KURA ONCOLOGY INC14 citations84
FENG JUN
2 patentsAUTOMATIC BAR CONTROLS INC
2 patents(unassigned)
1 patentANTAYA TIMOTHY A
1 patentNOVO NORDISK AS
1 patentUNIV MICHIGAN REGENTS
1 patentShowing the top 50 of 144 patents by PatentIndex Score.